PFE

Pfizer Inc

Apr 08 • 04:00PM ET

27.47

+0.37 1.37 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Apr 07, 12:01 PMTariff exposure from overseas manufacturing weighs on Pfizer shares amid policy concerns.

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM DVY VHT FDL

Scroll to Statements

Index	S&P 500	P/E	20.27	EPS (ttm)	1.36	Insider Own	0.10%	Shs Outstand	5.69B	Perf Week	-2.17%
Market Cap	156.20B	Forward P/E	9.77	EPS next Y	2.81	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	2.46%
Enterprise Value	210.32B	PEG	-	EPS next Q	0.73	Inst Own	66.97%	Short Float	2.31%	Perf Quarter	8.02%
Income	7.75B	P/S	2.50	EPS this Y	-8.19%	Inst Trans	0.25%	Short Ratio	2.90	Perf Half Y	3.93%
Sales	62.58B	P/B	1.81	EPS next Y	-4.85%	ROA	3.67%	Short Interest	131.41M	Perf YTD	10.32%
Book/sh	15.21	P/C	11.49	EPS next 5Y	-8.94%	ROE	8.87%	52W High	28.75 -4.44%	Perf Year	25.78%
Cash/sh	2.39	P/FCF	17.21	EPS past 3/5Y	-37.19% -3.57%	ROIC	5.15%	52W Low	20.92 31.34%	Perf 3Y	-33.81%
Dividend Est.	1.76 (6.41%)	EV/EBITDA	8.72	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	66.23%	Volatility	2.16% 2.24%	Perf 5Y	-23.61%
Dividend TTM	1.72 (6.26%)	EV/Sales	3.36	EPS Y/Y TTM	-3.74%	Oper. Margin	27.99%	ATR (14)	0.64	Perf 10Y	-10.81%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.87	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	51.36	Recom	2.59
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.16	EPS Q/Q	-509.90%	SMA20	0.39%	Beta	0.37	Target Price	28.52
Payout	126.85%	Debt/Eq	0.78	Sales Q/Q	-1.16%	SMA50	1.37%	Rel Volume	0.74	Prev Close	27.10
Employees	75000	LT Debt/Eq	0.74	Earnings	Feb 03 BMO	SMA200	7.68%	Avg Volume	45.32M	Price	27.47
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	33,764,171	Change	1.37%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50

Show Previous Ratings

Today 12:44PM	Gilead Agrees $5 Billion Tubulis Acquisition To Expand Cancer Drug Pipeline (GuruFocus.com)
Apr-07-26 05:47PM	The $190 Billion 'Diabesity' Market Is Set to Explode. Lilly and Novo Face These Stock Catalysts. (Barrons.com)
Apr-02-26 04:05PM	Trump slaps steep tariffs on patented drug imports (Supply Chain Dive)
11:37AM	Boost Pfizer's Already Hefty 6% Dividend Yield With A Covered Call (Investor's Business Daily)
08:01AM	JNJ Stocks 60% Breakout: Why Wall Street is Torn (Trefis)
04:07PM	Loading…
Apr-01-26 04:07PM	Why 2026 Is Biotech's Comeback Year (Barrons.com)
04:05PM	Oric Shares Fall 40% as Cancer-Drug Data Falls Short of Expectations (The Wall Street Journal)
10:02AM	Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer - And Plunges (Investor's Business Daily)
09:30AM	Pfizer Pulls Back From South San Francisco (GuruFocus.com)
04:00AM	Will Pfizers Lyme disease gamble pay off or set the space back? (Pharma Voice)
Mar-31-26 03:45PM	$2 Billion Bayer Verdict: What the Roundup Decision Means for MAHA (Exec Edge)
Mar-30-26 10:44AM	Pharma Stocks Pfizer, GSK Offer Defensive Plays in an Uncertain Market: Charts (Barrons.com)
09:37AM	Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. What It Means for the Stock. (Barrons.com)
09:17AM	Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. The Stock Rises. (Barrons.com)
02:03AM	Connecting Excellence Group appoints chief performance and growth officer (Proactive)
11:40AM	Loading…
Mar-27-26 11:40AM	Consecutive approvals of Opdivo for Hodgkins lymphoma to boost sales growth (Clinical Trials Arena)
Mar-26-26 01:30AM	22 S&P 500 Stocks Yield More Than 5%. 6 That Are Worth Buying. (Barrons.com)
Mar-24-26 11:02AM	Pfizer CFO Dave Denton Highlights Firms Recent Oncology Milestones (NYSE)
10:39AM	Pfizer Reports 73% Lyme Vaccine Efficacy as Trial Results Complicate Outlook (GuruFocus.com)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts (Business Wire)
05:57AM	Immutrin raises $87M to advance drug for progressive heart disease (BioPharma Dive)
Mar-23-26 02:31PM	Pfizer-Valneva Lyme disease vaccine falls short as low cases skew results (Clinical Trials Arena)
01:00PM	Stocks Rise, Oil Falls as Trump Eases Iran Threats: Markets Wrap (Bloomberg)
12:46PM	Pfizer's Lyme Vaccine Shows Strong Efficacy, but Misses Mark in Study (The Wall Street Journal)
09:54AM	Mixed results for Lyme disease vaccine hit Valneva shares (AFP)
08:06AM	Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results (BioPharma Dive)
08:00AM	Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation (TMX Newsfile)
07:07AM	Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial (MarketWatch)
07:02AM	Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial (The Wall Street Journal)
06:45AM	Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial (Business Wire)
09:00PM	Loading…
Mar-22-26 09:00PM	IP Group PLC (IPZYF) Full Year 2025 Earnings Call Highlights: Strong NAV Growth Amid Market ... (GuruFocus.com)
Mar-20-26 04:30PM	Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC (Business Wire)
Mar-19-26 09:47AM	ImmuPharma, Ilika, Coinsilium Group, IP Group, Team Internet Group - Small Cap Week in Review (Proactive)
07:37AM	Pfizer aims for wider use of PARP drug in prostate cancer with new data (BioPharma Dive)
07:30AM	The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients (Fortune)
06:45AM	TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer (Business Wire)
Mar-18-26 05:00PM	Valneva SE (INRLF) Full Year 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... (GuruFocus.com)
02:29PM	Analysis-TrumpRx lists many medicines at prices higher than paid in UK (Reuters)
Mar-17-26 03:01PM	Pfizer Reports Positive Mid-Stage Breast Cancer Trial Results (GuruFocus.com)
07:56AM	Bicycle to lay off 30% of staff, pivot away from Padcev challenger (BioPharma Dive)
07:15AM	Pfizers Ibrance successor moves forward with new study data (BioPharma Dive)
06:45AM	Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer (Business Wire)
05:53AM	Empire Metals, Atlantic Lithium, ImmuPharma, IP Group, Light Science Technologies, ATOME (Proactive)
Mar-16-26 11:38AM	IP Group CEO on 2025 highlights, NAV uplift, Pfizer royalties & capital allocation (Proactive)
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-13-26 11:38PM	Ecuador trade deal: Trump administration targets lower food and tech levies (Investing.com)
07:54AM	GSKs RSV vaccine wins broader FDA clearance (BioPharma Dive)
Mar-12-26 10:28AM	Starboard Value Is Betting Big on This Blue-Chip Dividend Stock. Should You? (Barchart)
07:00AM	The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income (Barchart)
Mar-11-26 12:41PM	Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials (Clinical Trials Arena)
Mar-10-26 04:20PM	Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up (Investor's Business Daily)
03:00PM	BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges (GuruFocus.com)
02:49PM	BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz (Benzinga)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
08:19AM	BioNTechs Founding Duo Will Leave to Start New mRNA Firm (Bloomberg)
07:18AM	BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. (Barrons.com)
07:00AM	Xenon hits a home run in epilepsy; FDA restarts review of Duchenne cell therapy (BioPharma Dive)
Mar-09-26 02:14PM	Roches oral SERD fails in Phase III breast cancer trial (Clinical Trials Arena)
01:42PM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
12:22PM	Why Is Olema Pharmaceuticals Stock Dropping On Monday? (Benzinga)
10:21AM	Roche Shares Drop Up to 7.5% After Breast Cancer Pill Misses Trial Goal (GuruFocus.com)
08:19AM	Roches prized breast cancer pill fails closely watched study (BioPharma Dive)
07:42AM	Stocks to Watch Monday: Moderna, Live Nation, Pfizer, Hims & Hers (The Wall Street Journal)
06:45AM	Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis (Business Wire)
05:44AM	Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study (The Wall Street Journal)
05:43AM	Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer, Hims & Hers (The Wall Street Journal)
Mar-08-26 04:49PM	These 8 drugs could help fight dementia - and they're already on the market (MarketWatch)
Mar-07-26 12:26PM	C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference (MarketBeat)
Mar-06-26 11:30AM	AbbVie (ABBV) Up 6.1% Since Last Earnings Report: Can It Continue? (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:14AM	China Clears Weight-Loss Shot As Pfizer Enters Crowded Market (Benzinga)
05:13AM	Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs (BioPharma Dive)
03:53AM	BridgeBio Pharma Talks Atrubie Momentum, Phase 3 Wins as Tafamidis IP Trial Looms (MarketBeat)
Mar-05-26 11:30AM	Pfizer (PFE) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
08:45AM	Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations? (Zacks)
Mar-04-26 08:54PM	Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline (Insider Monkey)
10:36AM	Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference (MarketBeat)
08:55AM	NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals (PR Newswire)
12:48AM	Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer (Insider Monkey)
Mar-03-26 07:24PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
03:35PM	The Dividend Safe Harbor: 2 Stocks to Watch (MarketBeat)
09:10AM	Immunology, Neuroscience Step Up as Key Growth Engines for J&J (Zacks)
Mar-02-26 12:42PM	BMY Gains 11.4% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
11:00AM	Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026? (Zacks)
09:53AM	Netflix upgraded, Pinterest downgraded: Wall Street's top analyst calls (The Fly)
Mar-01-26 04:27AM	Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM (Insider Monkey)
Feb-27-26 10:30AM	The Zacks Analyst Blog Highlights Meta Platforms, Netflix, Pfizer, SIFCO Industries and Altigen Communications (Zacks)
10:24AM	Amneal Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
10:00AM	PADCEV + Keytruda Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer (Business Wire)
08:26AM	Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates (Zacks)
07:01AM	Pfizer (PFE) Secures Full FDA Approval for BRAFTOVI as First-Line Treatment in mCRC (Insider Monkey)
12:07AM	Novavax Q4 Earnings Call Highlights (MarketBeat)
Feb-26-26 07:30PM	Love Dividends? 1 Stock to Buy Now With a Yield Over 6%. (Barchart)
04:11PM	Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
04:11PM	Top Research Reports for Meta, Netflix & Pfizer (Zacks)
02:24PM	Analyst Report: Viatris Inc. (Morningstar Research)
10:59AM	Aclaris Therapeutics Highlights AD and Asthma Data Catalysts at Oppenheimer Healthcare Conference (MarketBeat)
08:46AM	Novavax shares subdued despite earnings, revenue beat (Investing.com)
08:30AM	Novavax, Inc. Q4 2025 Earnings Call Summary (Moby)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your Finviz experience